NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

U.S. stocks mixed: Dow fell over 200 points, while Nasdaq and S&P 500 rose; inflation cooled and

Rafael Holdings (NYSE: RFL) stock tumbles after its Phase 3 TransportNPC study of Trappsol Cyclo mis

Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday'

U.S. stocks rose, led by tech, as Jabil beat Q4 estimates and raised FY2027 guidance; oil and gold a

Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 106.0% to $0.15 during Wednesday'

Trappsol® Cyclo™ was well tolerated and demonstrated a directionally favorable treatment effect on t

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.08) per share. This is a 57.89 percent i

The company has had a pre-NDA meeting with the FDA and expects to submit an NDA in second half of ca

Rafael Holdings, Inc. (NYSE:RFL) today announced that its subsidiary, Cyclo Therapeutics, has entere

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.13) per share. This is a 31.58 percent i

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 86.03 percent i

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today provided an update to the subscription rights relat

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today announced revised subscription rights in connection

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today announced a rights offering, including key dates an

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 416.67 percent

On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' sharehold

Rafael Holdings (NYSE:RFL) reported quarterly earnings of $0.06 per share. This is a 125 percent inc

Continued strong enrollment of pivotal Phase 3 global study (TransportNPC™) evaluating Trappsol® Cyc

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.06) per share. This is a 78.57 percent i

Rafael Holdings, Inc. (NYSE:RFL), today announced that its Board of Directors has authorized the rep

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.14) per share. This is a 16.67 percent d

The most overbought stocks in the real estate sector presents an opportunity to go short on these ov

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.22) per share. This is a 70.67 percent i

Rafael Holdings, Inc. (NYSE:RFL) today announced its decision to curtail its early-stage development

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.24) per share. This is a 68 percent incr

Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said

U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, mea

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.28) per share. This is a 86.67 percent d